Mastocytosis: New understandings in cutaneous pathophysiology

Journal of Dermatology

Volumn 23, Issue 11, 1996, Pages 769-772

  Lazarus, Gerald S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; CHYMASE; INTERFERON; INTERLEUKIN 3; PROSTAGLANDIN D2; TRYPTASE;

BRONCHIOLE; CONFERENCE PAPER; LUNG ALVEOLUS; MAST CELL; MASTOCYTOSIS; PROTO ONCOGENE; SKIN BIOPSY; ULTRAVIOLET A RADIATION; URTICARIA PIGMENTOSA;

EID: 0029844397     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb02699.x     Document Type: Conference Paper

References (15)

1. Barton J, Lavker RM, Schechter NM, Lazarus GS: Treatment of urticaria pigmentosa with corticosteroids, Arch Dennalol, 121: 1516-1523,1985.
2. Guzzo C, Lavker R, Roberts LJ, Fox K, Schechter N, Lazarus GS: Urticaria pigmentosum systemic evaluation and successful treatment with topical steroids, Arch Dennatol, 127: 191-196,1991.
3. Hamann K, Haas N, Brabbe J, Czarnetzki BM: Expression of stem cell factor in cutaneous mastocytosis, BrJ Dermalol, 133: 203-228, 1995.
4. Longley J, DufTy TP, Kohn S: The mast cell and mast cell disease,/ Am Academy of Derm, 32: 545-562, 1995.
5. Longley BJ, Morganroth GS, Tyrrell L, et al: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis, N Engt J Med, 328: 1302-1307,1993.
6. Mizutani H, Schechter NM, Lazarus GS, Black RA, Kupper TS: Rapid and specific conversion of precursor interleukin 16 to active IL-1 species by human mast cell chymasej Exp Med, 174: 821-825,1991.
7. Morrow JD, Guzzo C, Lazarus GS, Oates JA, Roberts LJ: Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2,/ Invest Dermatol, 104: 1-4,1995.
8. Nagata H, Wrobec AS, Chowdhvry BA, Tannenbaum S, Suzuki Y, Metacalfe DD: Identification of a point mutation in the catalytic domain of the proto oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associate hématologie disorder, Proc Natl Acad Sei USA, 92: 10560-10564,1995.
9. Pulik M, Lionnet F, Petit A, Genet P, Gaulier A: Long term response to interferon-alpha in a patient with systemic mastocytosis and chronic mylogenous leukemia, Am Journal of Hematology, 47: 66,1994.
10. Sayama S, lozzo RV, Lazarus GC, Schechter NM: Human skin chympotrypsin-like proteinase chymase, JBiol Chain, 262: 6308-6815,1987.
11. Schechter NM, Wang ZM, Blacher RW, Lessin SR, Lazarus GS, Rubin, H: Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions, J Immunol, 152: 4062-4069, 1994.
12. Schechter NM, Irani AA, Sprows JL, Abernethy J, Wintroub B, Schwanz LB: Identification of a cathespin G-like proteinase in the MCrc type of human mast cell, J Immunol, 145: 2652-2661,1990.
13. Schechter NM, Chol JK, Slavin DA, et al: Identification of a chymotrypsin-like proteinase in human mast cells,/ Immunol, 137: 962-970,1986.
14. Stege H, Schöpf E, RuzickaT, RrutmannJ: High-dose UVA, for urticaria pigmentosa, Lancet, 347: 64,1996.
15. Wmtroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwartz LB: Angiotensin I conversion by human rat chymotryptic proteinases.y Invest Dennatol, 83: 336-339,1984.